Annex A: Phase II and III studies, logo and trademark
Annex B: Registration Japan with total number of patients treated, results of comparative study with Omnipaque
Annex C:Clinical case studies
Annex D: All Iomeron import agreement
Annex E: All 3 modified comparative studies
Annex F: Trademark Situations in Japan
Annex G: All Trad English Preclinical comparative work Sakuma, plasma volume
Annex H: Acknowledgement for submitted documentation
Notes
Application for registration Japan, submitted on 28 May 1992